Course aim
This course offers a thorough exploration of CAR-T cell therapies (Chimeric Antigen Receptor T cell) within the realm of clinical trials. Participants will delve into the historical background of CAR-T therapies, their classifications, regulatory frameworks, safety considerations, mechanisms of action, and the role of viral vectors. Additionally, the course emphasizes Good Manufacturing Practice (GMP),addressing essential considerations, manufacturing processes, and quality control. By the end of the course, participants will have a solid understanding of CAR-T therapies in the context of clinical trials, including practical insights into managing CAR-T cell therapy trials and an overview of their clinical implementation.
The course will provide delegates an excellent opportunity to network with scientists and trial managers from the UCLCAR-T Programme, the most comprehensive programme in Europe to manufacture and deliver CAR-T cell therapies across a broad study portfolio.
Target audience
This is a comprehensive course suitable for everyone aiming at understanding CAR-T cell therapies in the context of oncology research and clinical trials.
Delegates should have a basic prior knowledge of cancer.
Course content
The course covers a mix of frontal lectures, quiz and group discussions that will include topics such as:
- The science behind CAR-T cell therapy design
- The use of different categories of viral vectors
- How are CAR-T cell therapies regulated
- Safety profiles of CAR-T cell therapies in oncology
- Manufacturing pipelines of CAR-T cell therapies
- Challenges in CAR-T cell therapy trial management and logistics
Courselecturers
- Claire Roddie, Consultant Haematologist, UCLH
- Mhairi Vaughan, GMP CAR T-cell technician, UCL & NHS Royal Free Hospital
- Yusuf Yaami, Regulatory Manager for Pharmaceuticals, JRO UCL
- Bilyana Popova, Senior Project Manager, CRUK & UCL Cancer Trials Centre
- Giulia Pellizzari, Lecturer in Cancer Clinical Trials, UCL
- Alison Evans, Regulatory Manager, JRO UCL
- Alice Piapi, Clinical Trials Monitor, CRUK & UCL Cancer Trials Centre
- Michelle Quaye, Regulatory Manager, JRO UCL